Silicon Laboratories (NASDAQ:SLAB) Shares Purchased by Great West Life Assurance Co. Can

Great West Life Assurance Co. Can boosted its stake in Silicon Laboratories (NASDAQ:SLAB) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,693 shares of the semiconductor company’s stock after purchasing an additional 648 shares during the quarter. Great West Life Assurance Co. Can owned about 0.06% of Silicon Laboratories worth $2,157,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. NumerixS Investment Technologies Inc bought a new position in shares of Silicon Laboratories during the 4th quarter worth approximately $71,000. Quadrant Capital Group LLC grew its stake in Silicon Laboratories by 866.0% in the 1st quarter. Quadrant Capital Group LLC now owns 995 shares of the semiconductor company’s stock valued at $79,000 after purchasing an additional 892 shares during the period. Advisor Group Inc. grew its stake in Silicon Laboratories by 13.9% in the 4th quarter. Advisor Group Inc. now owns 1,345 shares of the semiconductor company’s stock valued at $106,000 after purchasing an additional 164 shares during the period. FNY Investment Advisers LLC bought a new position in Silicon Laboratories in the 1st quarter valued at $161,000. Finally, Stephens Inc. AR grew its stake in Silicon Laboratories by 47.9% in the 4th quarter. Stephens Inc. AR now owns 2,015 shares of the semiconductor company’s stock valued at $159,000 after purchasing an additional 653 shares during the period. 92.05% of the stock is owned by hedge funds and other institutional investors.

NASDAQ:SLAB traded up $1.32 during trading hours on Friday, reaching $103.40. 524,554 shares of the company traded hands, compared to its average volume of 245,924. Silicon Laboratories has a 1 year low of $73.13 and a 1 year high of $110.43. The firm has a 50-day moving average price of $96.81. The company has a debt-to-equity ratio of 0.34, a current ratio of 6.04 and a quick ratio of 5.52. The firm has a market capitalization of $4.48 billion, a PE ratio of 36.15, a P/E/G ratio of 3.39 and a beta of 1.64.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Wednesday, April 24th. The semiconductor company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.47 by $0.12. The company had revenue of $188.11 million during the quarter, compared to analysts’ expectations of $188.02 million. Silicon Laboratories had a return on equity of 10.74% and a net margin of 7.35%. Silicon Laboratories’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.87 earnings per share. As a group, analysts anticipate that Silicon Laboratories will post 2.03 EPS for the current fiscal year.

In other news, Director Nina Richardson sold 913 shares of the company’s stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $91.41, for a total value of $83,457.33. Following the completion of the transaction, the director now owns 6,885 shares of the company’s stock, valued at $629,357.85. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jack R. Lazar sold 750 shares of the stock in a transaction that occurred on Thursday, April 25th. The shares were sold at an average price of $109.75, for a total value of $82,312.50. Following the transaction, the director now directly owns 14,391 shares of the company’s stock, valued at $1,579,412.25. The disclosure for this sale can be found here. Insiders own 2.10% of the company’s stock.

SLAB has been the subject of several research reports. BidaskClub downgraded Silicon Laboratories from a “hold” rating to a “sell” rating in a research note on Wednesday, March 27th. ValuEngine raised Silicon Laboratories from a “hold” rating to a “buy” rating in a report on Friday, April 19th. Zacks Investment Research raised Silicon Laboratories from a “hold” rating to a “strong-buy” rating and set a $122.00 price target on the stock in a report on Tuesday, April 30th. Roth Capital raised their price objective on Silicon Laboratories from $95.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 18th. Finally, MKM Partners lifted their price target on Silicon Laboratories to $105.00 in a research note on Thursday, April 25th. Seven analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $106.20.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, designs, develops, and markets mixed-signal integrated circuits (ICs) in the United States, China, and internationally. The company offers Internet of things products, including 8-bit mixed-signal, 32-bit wireless, and ultra-low-power 32-bit microcontrollers; wireless connectivity devices, such as multiprotocol wireless Gecko system-on-chip devices; real-time operating systems; sensor products comprising optical, relative humidity/temperature, and hall effect magnetic sensors.

Featured Story: How can you know how many shares are floating?

Institutional Ownership by Quarter for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.